Use of an antibody to target geldanamycin.
Mendelsohn
J
J
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000494:pharmacology* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D016227:Benzoquinones; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D047029:Lactams, Macrocyclic; D011809:Quinones / Q000494:pharmacology* / Q000627:therapeutic use; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000187:drug effects* / Q000378:metabolism*; D000068878:Trastuzumab; D015854:Up-Regulation / Q000187:drug effects
D000903:Antibiotics, Antineoplastic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016227:Benzoquinones; D047029:Lactams, Macrocyclic; D011809:Quinones; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C001277:geldanamycin